Pyridam Farma (Indonesia) Market Value
| PYFA Stock | IDR 236.00 8.00 3.28% |
| Symbol | Pyridam |
Pyridam Farma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pyridam Farma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pyridam Farma.
| 12/20/2023 |
| 12/14/2024 |
If you would invest 0.00 in Pyridam Farma on December 20, 2023 and sell it all today you would earn a total of 0.00 from holding Pyridam Farma Tbk or generate 0.0% return on investment in Pyridam Farma over 360 days. Pyridam Farma is related to or competes with Indofarma Tbk, Merck Tbk, Tempo Scan, Mustika Ratu, and Kimia Farma. More
Pyridam Farma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pyridam Farma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pyridam Farma Tbk upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.71 | |||
| Information Ratio | 0.1453 | |||
| Maximum Drawdown | 34.04 | |||
| Value At Risk | (6.94) | |||
| Potential Upside | 14.39 |
Pyridam Farma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pyridam Farma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pyridam Farma's standard deviation. In reality, there are many statistical measures that can use Pyridam Farma historical prices to predict the future Pyridam Farma's volatility.| Risk Adjusted Performance | 0.1258 | |||
| Jensen Alpha | 0.8587 | |||
| Total Risk Alpha | 0.2221 | |||
| Sortino Ratio | 0.1932 | |||
| Treynor Ratio | 0.6362 |
Pyridam Farma Tbk Backtested Returns
Pyridam Farma appears to be very steady, given 3 months investment horizon. Pyridam Farma Tbk maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. By analyzing Pyridam Farma's technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please evaluate Pyridam Farma's Risk Adjusted Performance of 0.1258, coefficient of variation of 619.85, and Semi Deviation of 3.57 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pyridam Farma holds a performance score of 10. The company holds a Beta of 1.57, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pyridam Farma will likely underperform. Please check Pyridam Farma's sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to make a quick decision on whether Pyridam Farma's historical price patterns will revert.
Auto-correlation | -0.91 |
Near perfect reversele predictability
Pyridam Farma Tbk has near perfect reversele predictability. Overlapping area represents the amount of predictability between Pyridam Farma time series from 20th of December 2023 to 17th of June 2024 and 17th of June 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pyridam Farma Tbk price movement. The serial correlation of -0.91 indicates that approximately 91.0% of current Pyridam Farma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.91 | |
| Spearman Rank Test | -0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 6060.72 |
Pyridam Farma Tbk lagged returns against current returns
Autocorrelation, which is Pyridam Farma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pyridam Farma's stock expected returns. We can calculate the autocorrelation of Pyridam Farma returns to help us make a trade decision. For example, suppose you find that Pyridam Farma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pyridam Farma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pyridam Farma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pyridam Farma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pyridam Farma stock over time.
Current vs Lagged Prices |
| Timeline |
Pyridam Farma Lagged Returns
When evaluating Pyridam Farma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pyridam Farma stock have on its future price. Pyridam Farma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pyridam Farma autocorrelation shows the relationship between Pyridam Farma stock current value and its past values and can show if there is a momentum factor associated with investing in Pyridam Farma Tbk.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Pyridam Stock
Pyridam Farma financial ratios help investors to determine whether Pyridam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pyridam with respect to the benefits of owning Pyridam Farma security.